Osteoarthritis Market 2027 By Treatment, Disease, End User | The Insight Partners

Osteoarthritis Market to 2027 - Global Analysis and Forecasts by Treatment (Drugs, Assistive Devices); Disease (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis); End User (Hospital Pharmacies, Retail pharmacies, Drug Stores, E-commerce.)

Report Code: TIPRE00004594 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Osteoarthritis is a degenerative disease if joint involving the joint lining, cartilage, underlying bone and ligaments. This disease generally affects the knee, hand, hip, and spine and is indicated by stiffness, pain, swelling, and limited motion of the affected joint.

MARKET DYNAMICS
The Osteoarthritis market is anticipated to grow in the forecast period owing to driving factors such as increasing lifestyle changes, growing number of obesity cases, rise in geriatric population, increasing cases of osteoarthritis, high awareness among the people, advancements in terms of technology and government reimbursement policies. Nevertheless, the stringent regulatory policies with respect to the administration of drugs is expected to hamper the market growth during the forecast period.

MARKET SCOPE
The "Global Osteoarthritis Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Osteoarthritis market with detailed market segmentation by Treatment, Disease, End User and geography. The global Osteoarthritis market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Osteoarthritis market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Osteoarthritis market is segmented on the basis of Treatment, Disease and End User. Based on Treatment the market is segmented into Drugs and Assistive Devices. Based on Disease the market is segmented into Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis and Hand Osteoarthritis. Based on End User the market is segmented into Hospital Pharmacies, Retail pharmacies, Drug Stores and E-commerce.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Osteoarthritis market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Osteoarthritis market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Osteoarthritis market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Osteoarthritis market in these regions.

MARKET PLAYERS
The reports cover key developments in the Osteoarthritis Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Osteoarthritis Market are anticipated to lucrative growth opportunities in the future with the rising demand for Osteoarthritis in the global market. Below mentioned is the list of few companies engaged in the Osteoarthritis market.

The report also includes the profiles of key Osteoarthritis market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Abbott Laboratories
  • Novartis AG
  • Pfizer, Inc
  • Abiogen Pharma Spa
  • Ampio Pharmaceuticals
  • BioDelivery Sciences International, Inc
  • Eli Lilly and Company
  • GlaxoSmithKline plc.
  • Sanofi SA
  • Stryker Corporation
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Osteoarthritis Market - By Treatment
1.3.2 Osteoarthritis Market - By Disease
1.3.3 Osteoarthritis Market - By End User
1.3.4 Osteoarthritis Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. OSTEOARTHRITIS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. OSTEOARTHRITIS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. OSTEOARTHRITIS MARKET - GLOBAL MARKET ANALYSIS
6.1. OSTEOARTHRITIS - GLOBAL MARKET OVERVIEW
6.2. OSTEOARTHRITIS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. OSTEOARTHRITIS MARKET - REVENUE AND FORECASTS TO 2027 - TREATMENT
7.1. OVERVIEW
7.2. TREATMENT MARKET FORECASTS AND ANALYSIS
7.3. DRUGS
7.3.1. Overview
7.3.2. Drugs Market Forecast and Analysis
7.4. ASSISTIVE DEVICES
7.4.1. Overview
7.4.2. Assistive Devices Market Forecast and Analysis
8. OSTEOARTHRITIS MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE
8.1. OVERVIEW
8.2. DISEASE MARKET FORECASTS AND ANALYSIS
8.3. KNEE OSTEOARTHRITIS
8.3.1. Overview
8.3.2. Knee Osteoarthritis Market Forecast and Analysis
8.4. SPINE OSTEOARTHRITIS
8.4.1. Overview
8.4.2. Spine Osteoarthritis Market Forecast and Analysis
8.5. FOOT AND ANKLE OSTEOARTHRITIS
8.5.1. Overview
8.5.2. Foot and Ankle Osteoarthritis Market Forecast and Analysis
8.6. SHOULDER OSTEOARTHRITIS
8.6.1. Overview
8.6.2. Shoulder Osteoarthritis Market Forecast and Analysis
8.7. HAND OSTEOARTHRITIS
8.7.1. Overview
8.7.2. Hand Osteoarthritis Market Forecast and Analysis
9. OSTEOARTHRITIS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail pharmacies Market Forecast and Analysis
9.5. DRUG STORES
9.5.1. Overview
9.5.2. Drug Stores Market Forecast and Analysis
9.6. E-COMMERCE.
9.6.1. Overview
9.6.2. E-commerce. Market Forecast and Analysis
10. OSTEOARTHRITIS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Osteoarthritis Market Overview
10.1.2 North America Osteoarthritis Market Forecasts and Analysis
10.1.3 North America Osteoarthritis Market Forecasts and Analysis - By Treatment
10.1.4 North America Osteoarthritis Market Forecasts and Analysis - By Disease
10.1.5 North America Osteoarthritis Market Forecasts and Analysis - By End User
10.1.6 North America Osteoarthritis Market Forecasts and Analysis - By Countries
10.1.6.1 United States Osteoarthritis Market
10.1.6.1.1 United States Osteoarthritis Market by Treatment
10.1.6.1.2 United States Osteoarthritis Market by Disease
10.1.6.1.3 United States Osteoarthritis Market by End User
10.1.6.2 Canada Osteoarthritis Market
10.1.6.2.1 Canada Osteoarthritis Market by Treatment
10.1.6.2.2 Canada Osteoarthritis Market by Disease
10.1.6.2.3 Canada Osteoarthritis Market by End User
10.1.6.3 Mexico Osteoarthritis Market
10.1.6.3.1 Mexico Osteoarthritis Market by Treatment
10.1.6.3.2 Mexico Osteoarthritis Market by Disease
10.1.6.3.3 Mexico Osteoarthritis Market by End User
10.1.6.4 US Osteoarthritis Market
10.1.6.4.1 US Osteoarthritis Market by Treatment
10.1.6.4.2 US Osteoarthritis Market by Disease
10.1.6.4.3 US Osteoarthritis Market by End User
10.2. EUROPE
10.2.1 Europe Osteoarthritis Market Overview
10.2.2 Europe Osteoarthritis Market Forecasts and Analysis
10.2.3 Europe Osteoarthritis Market Forecasts and Analysis - By Treatment
10.2.4 Europe Osteoarthritis Market Forecasts and Analysis - By Disease
10.2.5 Europe Osteoarthritis Market Forecasts and Analysis - By End User
10.2.6 Europe Osteoarthritis Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Osteoarthritis Market
10.2.6.1.1 Germany Osteoarthritis Market by Treatment
10.2.6.1.2 Germany Osteoarthritis Market by Disease
10.2.6.1.3 Germany Osteoarthritis Market by End User
10.2.6.2 France Osteoarthritis Market
10.2.6.2.1 France Osteoarthritis Market by Treatment
10.2.6.2.2 France Osteoarthritis Market by Disease
10.2.6.2.3 France Osteoarthritis Market by End User
10.2.6.3 Italy Osteoarthritis Market
10.2.6.3.1 Italy Osteoarthritis Market by Treatment
10.2.6.3.2 Italy Osteoarthritis Market by Disease
10.2.6.3.3 Italy Osteoarthritis Market by End User
10.2.6.4 Spain Osteoarthritis Market
10.2.6.4.1 Spain Osteoarthritis Market by Treatment
10.2.6.4.2 Spain Osteoarthritis Market by Disease
10.2.6.4.3 Spain Osteoarthritis Market by End User
10.2.6.5 United Kingdom Osteoarthritis Market
10.2.6.5.1 United Kingdom Osteoarthritis Market by Treatment
10.2.6.5.2 United Kingdom Osteoarthritis Market by Disease
10.2.6.5.3 United Kingdom Osteoarthritis Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Osteoarthritis Market Overview
10.3.2 Asia-Pacific Osteoarthritis Market Forecasts and Analysis
10.3.3 Asia-Pacific Osteoarthritis Market Forecasts and Analysis - By Treatment
10.3.4 Asia-Pacific Osteoarthritis Market Forecasts and Analysis - By Disease
10.3.5 Asia-Pacific Osteoarthritis Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Osteoarthritis Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Osteoarthritis Market
10.3.6.1.1 Australia Osteoarthritis Market by Treatment
10.3.6.1.2 Australia Osteoarthritis Market by Disease
10.3.6.1.3 Australia Osteoarthritis Market by End User
10.3.6.2 China Osteoarthritis Market
10.3.6.2.1 China Osteoarthritis Market by Treatment
10.3.6.2.2 China Osteoarthritis Market by Disease
10.3.6.2.3 China Osteoarthritis Market by End User
10.3.6.3 India Osteoarthritis Market
10.3.6.3.1 India Osteoarthritis Market by Treatment
10.3.6.3.2 India Osteoarthritis Market by Disease
10.3.6.3.3 India Osteoarthritis Market by End User
10.3.6.4 Japan Osteoarthritis Market
10.3.6.4.1 Japan Osteoarthritis Market by Treatment
10.3.6.4.2 Japan Osteoarthritis Market by Disease
10.3.6.4.3 Japan Osteoarthritis Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Osteoarthritis Market Overview
10.4.2 Middle East and Africa Osteoarthritis Market Forecasts and Analysis
10.4.3 Middle East and Africa Osteoarthritis Market Forecasts and Analysis - By Treatment
10.4.4 Middle East and Africa Osteoarthritis Market Forecasts and Analysis - By Disease
10.4.5 Middle East and Africa Osteoarthritis Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Osteoarthritis Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Osteoarthritis Market
10.4.6.1.1 South Africa Osteoarthritis Market by Treatment
10.4.6.1.2 South Africa Osteoarthritis Market by Disease
10.4.6.1.3 South Africa Osteoarthritis Market by End User
10.4.6.2 Saudi Arabia Osteoarthritis Market
10.4.6.2.1 Saudi Arabia Osteoarthritis Market by Treatment
10.4.6.2.2 Saudi Arabia Osteoarthritis Market by Disease
10.4.6.2.3 Saudi Arabia Osteoarthritis Market by End User
10.4.6.3 U.A.E Osteoarthritis Market
10.4.6.3.1 U.A.E Osteoarthritis Market by Treatment
10.4.6.3.2 U.A.E Osteoarthritis Market by Disease
10.4.6.3.3 U.A.E Osteoarthritis Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Osteoarthritis Market Overview
10.5.2 South and Central America Osteoarthritis Market Forecasts and Analysis
10.5.3 South and Central America Osteoarthritis Market Forecasts and Analysis - By Treatment
10.5.4 South and Central America Osteoarthritis Market Forecasts and Analysis - By Disease
10.5.5 South and Central America Osteoarthritis Market Forecasts and Analysis - By End User
10.5.6 South and Central America Osteoarthritis Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Osteoarthritis Market
10.5.6.1.1 Brazil Osteoarthritis Market by Treatment
10.5.6.1.2 Brazil Osteoarthritis Market by Disease
10.5.6.1.3 Brazil Osteoarthritis Market by End User
10.5.6.2 Argentina Osteoarthritis Market
10.5.6.2.1 Argentina Osteoarthritis Market by Treatment
10.5.6.2.2 Argentina Osteoarthritis Market by Disease
10.5.6.2.3 Argentina Osteoarthritis Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. OSTEOARTHRITIS MARKET, KEY COMPANY PROFILES
12.1. ABBOTT LABORATORIES
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. NOVARTIS AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PFIZER, INC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ABIOGEN PHARMA SPA
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. AMPIO PHARMACEUTICALS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BIODELIVERY SCIENCES INTERNATIONAL, INC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ELI LILLY AND COMPANY
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. GLAXOSMITHKLINE PLC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SANOFI SA
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. STRYKER CORPORATION
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TER
The List of Companies

- Abbott Laboratories
- Novartis AG
- Pfizer, Inc
- Abiogen Pharma Spa
- Ampio Pharmaceuticals
- BioDelivery Sciences International, Inc
- Eli Lilly and Company
- GlaxoSmithKline plc.
- Sanofi SA
- Stryker Corporation